| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 2.98e-06 | 2 | 35 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 2.98e-06 | 2 | 35 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 8.94e-06 | 3 | 35 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.52e-05 | 86 | 35 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | histone H3K9 monomethyltransferase activity | 8.30e-05 | 8 | 35 | 2 | GO:0140948 | |
| GeneOntologyMolecularFunction | zinc ion binding | 1.22e-04 | 891 | 35 | 8 | GO:0008270 | |
| GeneOntologyMolecularFunction | histone H3K9me2 methyltransferase activity | 1.33e-04 | 10 | 35 | 2 | GO:0140947 | |
| GeneOntologyMolecularFunction | histone H3K9 methyltransferase activity | 2.30e-04 | 13 | 35 | 2 | GO:0046974 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 3.09e-04 | 15 | 35 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.53e-04 | 16 | 35 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | methyltransferase activity | 5.09e-04 | 213 | 35 | 4 | GO:0008168 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 6.14e-04 | 21 | 35 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 6.14e-04 | 21 | 35 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | transferase activity, transferring one-carbon groups | 6.14e-04 | 224 | 35 | 4 | GO:0016741 | |
| GeneOntologyMolecularFunction | histone modifying activity | 6.67e-04 | 229 | 35 | 4 | GO:0140993 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 8.18e-04 | 105 | 35 | 3 | GO:0008170 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 8.58e-04 | 1189 | 35 | 8 | GO:0046914 | |
| GeneOntologyMolecularFunction | actin binding | 1.39e-03 | 479 | 35 | 5 | GO:0003779 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 1.91e-03 | 37 | 35 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TRIM54 SPATA31A1 SPATA31A3 SPATA31A6 SPATA31A5 EP300 SPATA31A7 | 2.60e-03 | 1099 | 35 | 7 | GO:0008092 |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 2.70e-03 | 44 | 35 | 2 | GO:0140938 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 3.09e-03 | 167 | 35 | 3 | GO:0031490 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 3.36e-03 | 172 | 35 | 3 | GO:0008757 | |
| GeneOntologyMolecularFunction | integrin binding | 3.52e-03 | 175 | 35 | 3 | GO:0005178 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 3.61e-03 | 51 | 35 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 4.03e-03 | 54 | 35 | 2 | GO:0001223 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 4.18e-03 | 55 | 35 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.31e-03 | 188 | 35 | 3 | GO:0005201 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 4.96e-03 | 60 | 35 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 5.55e-03 | 206 | 35 | 3 | GO:0140030 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 6.32e-03 | 68 | 35 | 2 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 6.51e-03 | 69 | 35 | 2 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 6.88e-03 | 71 | 35 | 2 | GO:0042054 | |
| GeneOntologyMolecularFunction | p53 binding | 8.04e-03 | 77 | 35 | 2 | GO:0002039 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 8.25e-03 | 78 | 35 | 2 | GO:0008080 | |
| GeneOntologyMolecularFunction | calcium ion binding | 9.36e-03 | 749 | 35 | 5 | GO:0005509 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 9.51e-03 | 84 | 35 | 2 | GO:0003684 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 9.73e-03 | 85 | 35 | 2 | GO:0038024 | |
| GeneOntologyMolecularFunction | methylated histone binding | 9.95e-03 | 86 | 35 | 2 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 1.04e-02 | 88 | 35 | 2 | GO:0140034 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 1.07e-02 | 775 | 35 | 5 | GO:0016746 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1.21e-02 | 1459 | 35 | 7 | GO:0000977 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 1.38e-02 | 102 | 35 | 2 | GO:0016410 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 1.40e-02 | 103 | 35 | 2 | GO:0008276 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 1.43e-02 | 104 | 35 | 2 | GO:0016407 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 6.37e-06 | 276 | 35 | 6 | GO:0007179 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 8.28e-06 | 445 | 35 | 7 | GO:0141091 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.39e-05 | 482 | 35 | 7 | GO:0007178 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 1.67e-05 | 4 | 35 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 1.72e-05 | 192 | 35 | 5 | GO:0017015 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 1.85e-05 | 195 | 35 | 5 | GO:1903844 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 1.95e-05 | 336 | 35 | 6 | GO:0071560 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 2.19e-05 | 343 | 35 | 6 | GO:0071559 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 2.82e-05 | 35 | 35 | 3 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 2.82e-05 | 35 | 35 | 3 | GO:0030511 | |
| GeneOntologyBiologicalProcess | positive regulation of sarcomere organization | 5.84e-05 | 7 | 35 | 2 | GO:0060298 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 7.03e-05 | 850 | 35 | 8 | GO:0071363 | |
| GeneOntologyBiologicalProcess | response to growth factor | 9.18e-05 | 883 | 35 | 8 | GO:0070848 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta1 production | 2.16e-04 | 13 | 35 | 2 | GO:0032905 | |
| GeneOntologyBiologicalProcess | regulation of sarcomere organization | 2.16e-04 | 13 | 35 | 2 | GO:0060297 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.81e-04 | 347 | 35 | 5 | GO:0090092 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid acetylation | 3.31e-04 | 16 | 35 | 2 | GO:0006474 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 3.31e-04 | 16 | 35 | 2 | GO:1900034 | |
| GeneOntologyBiologicalProcess | cellular response to heat | 3.49e-04 | 81 | 35 | 3 | GO:0034605 | |
| GeneOntologyBiologicalProcess | positive regulation by host of viral transcription | 3.74e-04 | 17 | 35 | 2 | GO:0043923 | |
| GeneOntologyBiologicalProcess | positive regulation of cell size | 4.70e-04 | 19 | 35 | 2 | GO:0045793 | |
| GeneOntologyBiologicalProcess | modulation by host of symbiont process | 4.91e-04 | 91 | 35 | 3 | GO:0051851 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 6.15e-04 | 412 | 35 | 5 | GO:0090287 | |
| GeneOntologyBiologicalProcess | methylation | 6.41e-04 | 234 | 35 | 4 | GO:0032259 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 6.82e-04 | 1186 | 35 | 8 | GO:0007167 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion molecule production | 6.92e-04 | 23 | 35 | 2 | GO:0060353 | |
| GeneOntologyBiologicalProcess | stimulatory C-type lectin receptor signaling pathway | 6.92e-04 | 23 | 35 | 2 | GO:0002223 | |
| GeneOntologyBiologicalProcess | cellular response to lectin | 6.92e-04 | 23 | 35 | 2 | GO:1990858 | |
| GeneOntologyBiologicalProcess | response to lectin | 6.92e-04 | 23 | 35 | 2 | GO:1990840 | |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | ZNF449 SMCP SPATA31A1 SPATA31A3 SPATA31A6 SPATA31A5 LIN28A SPATA31A7 | 7.13e-04 | 1194 | 35 | 8 | GO:0048609 |
| GeneOntologyBiologicalProcess | positive regulation of muscle cell differentiation | 7.66e-04 | 106 | 35 | 3 | GO:0051149 | |
| GeneOntologyBiologicalProcess | cell adhesion molecule production | 8.86e-04 | 26 | 35 | 2 | GO:0060352 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell chemotaxis | 8.86e-04 | 26 | 35 | 2 | GO:2001026 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to nucleus | 9.46e-04 | 114 | 35 | 3 | GO:1900182 | |
| GeneOntologyBiologicalProcess | peptide cross-linking | 9.56e-04 | 27 | 35 | 2 | GO:0018149 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 9.70e-04 | 115 | 35 | 3 | GO:0090100 | |
| GeneOntologyBiologicalProcess | cellular response to nutrient levels | 9.77e-04 | 262 | 35 | 4 | GO:0031669 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine acetylation | 1.03e-03 | 28 | 35 | 2 | GO:0018394 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell differentiation | 1.10e-03 | 29 | 35 | 2 | GO:0090335 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid modification | 1.10e-03 | 29 | 35 | 2 | GO:0031365 | |
| GeneOntologyBiologicalProcess | response to heat | 1.12e-03 | 121 | 35 | 3 | GO:0009408 | |
| GeneOntologyBiologicalProcess | gamete generation | ZNF449 SPATA31A1 SPATA31A3 SPATA31A6 SPATA31A5 LIN28A SPATA31A7 | 1.13e-03 | 982 | 35 | 7 | GO:0007276 |
| GeneOntologyBiologicalProcess | respiratory tube development | 1.14e-03 | 273 | 35 | 4 | GO:0030323 | |
| GeneOntologyBiologicalProcess | sexual reproduction | ZNF449 SMCP SPATA31A1 SPATA31A3 SPATA31A6 SPATA31A5 LIN28A SPATA31A7 | 1.32e-03 | 1312 | 35 | 8 | GO:0019953 |
| GeneOntologyBiologicalProcess | spermatogenesis | 1.43e-03 | 744 | 35 | 6 | GO:0007283 | |
| GeneOntologyBiologicalProcess | biological process involved in interaction with symbiont | 1.54e-03 | 135 | 35 | 3 | GO:0051702 | |
| GeneOntologyBiologicalProcess | endothelial cell chemotaxis | 1.61e-03 | 35 | 35 | 2 | GO:0035767 | |
| GeneOntologyBiologicalProcess | male gamete generation | 1.62e-03 | 762 | 35 | 6 | GO:0048232 | |
| GeneOntologyCellularComponent | acrosomal vesicle | 2.26e-05 | 206 | 35 | 5 | GO:0001669 | |
| HumanPheno | Abnormal atrioventricular valve morphology | 1.77e-06 | 350 | 11 | 7 | HP:0006705 | |
| HumanPheno | Mitral valve prolapse | 3.11e-06 | 123 | 11 | 5 | HP:0001634 | |
| HumanPheno | Plantar crease between first and second toes | 4.24e-06 | 2 | 11 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 4.24e-06 | 2 | 11 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 4.24e-06 | 2 | 11 | 2 | HP:0001042 | |
| HumanPheno | Pulmonic stenosis | 5.50e-06 | 138 | 11 | 5 | HP:0001642 | |
| HumanPheno | Abnormal mitral valve morphology | 5.81e-06 | 257 | 11 | 6 | HP:0001633 | |
| HumanPheno | Dental crowding | 6.79e-06 | 144 | 11 | 5 | HP:0000678 | |
| HumanPheno | Abnormal mitral valve morphology | 7.26e-06 | 146 | 11 | 5 | HP:0031477 | |
| HumanPheno | Broad phalanx | 7.77e-06 | 148 | 11 | 5 | HP:0006009 | |
| HumanPheno | Broad phalanges of the hand | 7.77e-06 | 148 | 11 | 5 | HP:0009768 | |
| HumanPheno | Absent earlobe | 8.37e-06 | 20 | 11 | 3 | HP:0000387 | |
| HumanPheno | Broad finger | 9.44e-06 | 154 | 11 | 5 | HP:0001500 | |
| HumanPheno | Deep plantar creases | 9.76e-06 | 21 | 11 | 3 | HP:0001869 | |
| HumanPheno | Corneal scarring | 9.76e-06 | 21 | 11 | 3 | HP:0000559 | |
| HumanPheno | High, narrow palate | 1.01e-05 | 156 | 11 | 5 | HP:0002705 | |
| HumanPheno | Abnormal eyebrow morphology | 1.03e-05 | 674 | 11 | 8 | HP:0000534 | |
| HumanPheno | Broad long bones | 1.04e-05 | 157 | 11 | 5 | HP:0005622 | |
| HumanPheno | Abnormal pulmonary valve physiology | 1.25e-05 | 163 | 11 | 5 | HP:0031654 | |
| HumanPheno | Laryngeal cartilage malformation | 1.27e-05 | 3 | 11 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 1.27e-05 | 3 | 11 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 1.27e-05 | 3 | 11 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 1.27e-05 | 3 | 11 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 1.27e-05 | 3 | 11 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 1.27e-05 | 3 | 11 | 2 | HP:0005895 | |
| HumanPheno | Deep philtrum | 1.32e-05 | 75 | 11 | 4 | HP:0002002 | |
| HumanPheno | Minor feet anomalies | 1.90e-05 | 26 | 11 | 3 | HP:0010613 | |
| HumanPheno | Abnormal feet morphology | 1.90e-05 | 26 | 11 | 3 | HP:0010611 | |
| HumanPheno | Broad distal phalanx of finger | 2.13e-05 | 27 | 11 | 3 | HP:0009836 | |
| HumanPheno | Smooth philtrum | 2.32e-05 | 185 | 11 | 5 | HP:0000319 | |
| HumanPheno | Trichiasis | 2.54e-05 | 4 | 11 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 2.54e-05 | 4 | 11 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 2.54e-05 | 4 | 11 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 2.54e-05 | 4 | 11 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 2.54e-05 | 4 | 11 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 2.54e-05 | 4 | 11 | 2 | HP:0031207 | |
| HumanPheno | Broad eyebrow | 2.66e-05 | 29 | 11 | 3 | HP:0011229 | |
| HumanPheno | Flared metaphysis | 2.70e-05 | 191 | 11 | 5 | HP:0003015 | |
| HumanPheno | Abnormal pulmonary valve morphology | 3.22e-05 | 198 | 11 | 5 | HP:0001641 | |
| HumanPheno | Narrow palate | 3.55e-05 | 202 | 11 | 5 | HP:0000189 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 4.22e-05 | 5 | 11 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 4.22e-05 | 5 | 11 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 4.22e-05 | 5 | 11 | 2 | HP:0030421 | |
| HumanPheno | Aspiration | 4.32e-05 | 34 | 11 | 3 | HP:0002835 | |
| HumanPheno | Scarring | 4.49e-05 | 102 | 11 | 4 | HP:0100699 | |
| HumanPheno | Abnormal heart valve morphology | 5.73e-05 | 588 | 11 | 7 | HP:0001654 | |
| HumanPheno | Large foramen magnum | 6.33e-05 | 6 | 11 | 2 | HP:0002700 | |
| HumanPheno | Metaphyseal widening | 6.92e-05 | 232 | 11 | 5 | HP:0003016 | |
| HumanPheno | Narrow mouth | 7.22e-05 | 234 | 11 | 5 | HP:0000160 | |
| HumanPheno | Abnormal heart valve physiology | 7.75e-05 | 403 | 11 | 6 | HP:0031653 | |
| HumanPheno | Abnormal toe morphology | 8.67e-05 | 893 | 11 | 8 | HP:0001780 | |
| HumanPheno | Deviated nasal septum | 8.85e-05 | 7 | 11 | 2 | HP:0004411 | |
| HumanPheno | Hip dysplasia | 9.35e-05 | 247 | 11 | 5 | HP:0001385 | |
| HumanPheno | Tooth malposition | 9.53e-05 | 418 | 11 | 6 | HP:0000692 | |
| HumanPheno | Prominent fingertip pads | 1.08e-04 | 46 | 11 | 3 | HP:0001212 | |
| HumanPheno | Long eyelashes | 1.13e-04 | 129 | 11 | 4 | HP:0000527 | |
| HumanPheno | Abnormal morphology of bones of the upper limbs | 1.21e-04 | 436 | 11 | 6 | HP:0040065 | |
| HumanPheno | Prominent digit pad | 1.23e-04 | 48 | 11 | 3 | HP:0011298 | |
| HumanPheno | Abnormal nasal dorsum morphology | 1.24e-04 | 262 | 11 | 5 | HP:0011119 | |
| HumanPheno | Deeply set eye | 1.33e-04 | 266 | 11 | 5 | HP:0000490 | |
| HumanPheno | Abnormal lacrimal duct morphology | 1.39e-04 | 50 | 11 | 3 | HP:0011481 | |
| HumanPheno | Cutaneous syndactyly of toes | 1.39e-04 | 50 | 11 | 3 | HP:0010621 | |
| HumanPheno | Pilomatrixoma | 1.51e-04 | 9 | 11 | 2 | HP:0030434 | |
| HumanPheno | Cervical cord compression | 1.51e-04 | 9 | 11 | 2 | HP:0002341 | |
| HumanPheno | Aplasia/Hypoplasia of the earlobes | 1.65e-04 | 53 | 11 | 3 | HP:0009906 | |
| HumanPheno | Narrow nasal bridge | 1.65e-04 | 53 | 11 | 3 | HP:0000446 | |
| HumanPheno | Abnormal eyelash morphology | 1.82e-04 | 284 | 11 | 5 | HP:0000499 | |
| HumanPheno | Duplication involving bones of the feet | 1.88e-04 | 147 | 11 | 4 | HP:0009136 | |
| HumanPheno | Foot polydactyly | 1.88e-04 | 147 | 11 | 4 | HP:0001829 | |
| HumanPheno | Frontal hirsutism | 1.89e-04 | 10 | 11 | 2 | HP:0011335 | |
| HumanPheno | Hypermetropia | 1.94e-04 | 288 | 11 | 5 | HP:0000540 | |
| HumanPheno | Abnormality of refraction | 1.95e-04 | 709 | 11 | 7 | HP:0000539 | |
| HumanPheno | Abnormal upper limb bone morphology | 2.18e-04 | 484 | 11 | 6 | HP:0040070 | |
| HumanPheno | Abnormal subclavian artery morphology | 2.31e-04 | 11 | 11 | 2 | HP:0031251 | |
| HumanPheno | Abnormal dental morphology | 2.32e-04 | 299 | 11 | 5 | HP:0006482 | |
| HumanPheno | Abnormal hip joint morphology | 2.33e-04 | 490 | 11 | 6 | HP:0001384 | |
| HumanPheno | Abnormal finger morphology | 2.51e-04 | 1385 | 11 | 9 | HP:0001167 | |
| HumanPheno | Frontal bossing | 2.53e-04 | 738 | 11 | 7 | HP:0002007 | |
| HumanPheno | Abnormal finger phalanx morphology | 2.53e-04 | 738 | 11 | 7 | HP:0005918 | |
| HumanPheno | Short phalanx of finger | 2.59e-04 | 306 | 11 | 5 | HP:0009803 | |
| HumanPheno | Abnormal shape of the frontal region | 2.59e-04 | 741 | 11 | 7 | HP:0011218 | |
| HumanPheno | Abnormal frontal bone morphology | 2.61e-04 | 742 | 11 | 7 | HP:0430000 | |
| HumanPheno | Abnormal synovial membrane morphology | 2.70e-04 | 503 | 11 | 6 | HP:0005262 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the hand | 3.15e-04 | 319 | 11 | 5 | HP:0009767 | |
| HumanPheno | Abnormal hair morphology | 3.17e-04 | 1424 | 11 | 9 | HP:0001595 | |
| HumanPheno | Facial grimacing | 3.26e-04 | 13 | 11 | 2 | HP:0000273 | |
| HumanPheno | Keloids | 3.26e-04 | 13 | 11 | 2 | HP:0010562 | |
| HumanPheno | Duplication of phalanx of hallux | 3.80e-04 | 14 | 11 | 2 | HP:0010066 | |
| HumanPheno | Hypoplastic aortic arch | 3.80e-04 | 14 | 11 | 2 | HP:0012304 | |
| HumanPheno | Parietal foramina | 3.80e-04 | 14 | 11 | 2 | HP:0002697 | |
| HumanPheno | Pulmonary artery dilatation | 3.80e-04 | 14 | 11 | 2 | HP:0004927 | |
| HumanPheno | Duplication of phalanx of toe | 4.38e-04 | 15 | 11 | 2 | HP:0010181 | |
| HumanPheno | Social and occupational deterioration | 4.38e-04 | 15 | 11 | 2 | HP:0007086 | |
| HumanPheno | Atypical scarring of skin | 4.47e-04 | 74 | 11 | 3 | HP:0000987 | |
| HumanPheno | Abnormal metaphysis morphology | 4.49e-04 | 344 | 11 | 5 | HP:0000944 | |
| HumanPheno | Scoliosis | 4.69e-04 | 1122 | 11 | 8 | HP:0002650 | |
| HumanPheno | Square face | 5.00e-04 | 16 | 11 | 2 | HP:0000321 | |
| HumanPheno | Lipoatrophy | 5.42e-04 | 79 | 11 | 3 | HP:0100578 | |
| HumanPheno | Premature thelarche | 5.67e-04 | 17 | 11 | 2 | HP:0010314 | |
| HumanPheno | Abnormal aortic morphology | 5.77e-04 | 363 | 11 | 5 | HP:0030963 | |
| MousePheno | abnormal heart ventricle morphology | 6.48e-05 | 793 | 26 | 8 | MP:0005294 | |
| MousePheno | aortic dissection | 1.19e-04 | 9 | 26 | 2 | MP:0004044 | |
| MousePheno | abnormal maxilla morphology | 1.35e-04 | 144 | 26 | 4 | MP:0000455 | |
| MousePheno | hemorrhage | 1.57e-04 | 664 | 26 | 7 | MP:0001914 | |
| Domain | DUF4599 | 3.96e-09 | 12 | 33 | 4 | PF15371 | |
| Domain | DUF4599 | 3.96e-09 | 12 | 33 | 4 | IPR027970 | |
| Domain | EGF_3 | 1.48e-07 | 235 | 33 | 7 | PS50026 | |
| Domain | EGF | 1.48e-07 | 235 | 33 | 7 | SM00181 | |
| Domain | EGF-like_dom | 2.19e-07 | 249 | 33 | 7 | IPR000742 | |
| Domain | EGF_1 | 2.57e-07 | 255 | 33 | 7 | PS00022 | |
| Domain | EGF-like_CS | 3.01e-07 | 261 | 33 | 7 | IPR013032 | |
| Domain | EGF_2 | 3.33e-07 | 265 | 33 | 7 | PS01186 | |
| Domain | EGF_CA | 2.25e-06 | 122 | 33 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.43e-06 | 124 | 33 | 5 | IPR001881 | |
| Domain | - | 3.03e-06 | 2 | 33 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 3.03e-06 | 2 | 33 | 2 | PF02135 | |
| Domain | ZF_TAZ | 3.03e-06 | 2 | 33 | 2 | PS50134 | |
| Domain | Nuc_rcpt_coact_CREBbp | 3.03e-06 | 2 | 33 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 3.03e-06 | 2 | 33 | 2 | PF08214 | |
| Domain | KIX | 3.03e-06 | 2 | 33 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 3.03e-06 | 2 | 33 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 3.03e-06 | 2 | 33 | 2 | IPR031162 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 3.03e-06 | 2 | 33 | 2 | IPR013178 | |
| Domain | DUF902 | 3.03e-06 | 2 | 33 | 2 | PF06001 | |
| Domain | - | 3.03e-06 | 2 | 33 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 3.03e-06 | 2 | 33 | 2 | IPR010303 | |
| Domain | KAT11 | 3.03e-06 | 2 | 33 | 2 | SM01250 | |
| Domain | - | 3.03e-06 | 2 | 33 | 2 | 1.10.1630.10 | |
| Domain | Znf_TAZ | 3.03e-06 | 2 | 33 | 2 | IPR000197 | |
| Domain | KIX_dom | 3.03e-06 | 2 | 33 | 2 | IPR003101 | |
| Domain | Creb_binding | 3.03e-06 | 2 | 33 | 2 | PF09030 | |
| Domain | KIX | 3.03e-06 | 2 | 33 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 3.03e-06 | 2 | 33 | 2 | PS51727 | |
| Domain | EGF_CA | 1.55e-05 | 86 | 33 | 4 | PF07645 | |
| Domain | Nuc_rcpt_coact | 4.52e-05 | 6 | 33 | 2 | IPR009110 | |
| Domain | SET | 7.24e-05 | 46 | 33 | 3 | SM00317 | |
| Domain | SET_dom | 9.31e-05 | 50 | 33 | 3 | IPR001214 | |
| Domain | SET | 9.31e-05 | 50 | 33 | 3 | PS50280 | |
| Domain | Growth_fac_rcpt_ | 1.59e-04 | 156 | 33 | 4 | IPR009030 | |
| Domain | ZF_ZZ_2 | 4.55e-04 | 18 | 33 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 4.55e-04 | 18 | 33 | 2 | PS01357 | |
| Domain | ZZ | 4.55e-04 | 18 | 33 | 2 | PF00569 | |
| Domain | Znf_ZZ | 5.08e-04 | 19 | 33 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 5.08e-04 | 19 | 33 | 2 | SM00291 | |
| Domain | EGF_Ca-bd_CS | 6.62e-04 | 97 | 33 | 3 | IPR018097 | |
| Domain | EGF_CA | 7.02e-04 | 99 | 33 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 7.23e-04 | 100 | 33 | 3 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 8.57e-04 | 106 | 33 | 3 | IPR000152 | |
| Domain | cEGF | 9.58e-04 | 26 | 33 | 2 | IPR026823 | |
| Domain | cEGF | 9.58e-04 | 26 | 33 | 2 | PF12662 | |
| Domain | Bromodomain_CS | 9.58e-04 | 26 | 33 | 2 | IPR018359 | |
| Domain | VWC | 1.11e-03 | 28 | 33 | 2 | PF00093 | |
| Domain | EGF | 1.41e-03 | 126 | 33 | 3 | PF00008 | |
| Domain | ZF_RING_1 | 1.65e-03 | 291 | 33 | 4 | PS00518 | |
| Domain | ZF_RING_2 | 1.80e-03 | 298 | 33 | 4 | PS50089 | |
| Domain | VWFC_1 | 1.84e-03 | 36 | 33 | 2 | PS01208 | |
| Domain | BROMODOMAIN_1 | 1.94e-03 | 37 | 33 | 2 | PS00633 | |
| Domain | VWC | 2.05e-03 | 38 | 33 | 2 | SM00214 | |
| Domain | Bromodomain | 2.05e-03 | 38 | 33 | 2 | PF00439 | |
| Domain | VWFC_2 | 2.05e-03 | 38 | 33 | 2 | PS50184 | |
| Domain | ZINC_FINGER_C2H2_2 | 2.12e-03 | 775 | 33 | 6 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 2.15e-03 | 777 | 33 | 6 | PS00028 | |
| Domain | zf-C2H2_6 | 2.18e-03 | 314 | 33 | 4 | PF13912 | |
| Domain | LDLR_class-A_CS | 2.26e-03 | 40 | 33 | 2 | IPR023415 | |
| Domain | BROMODOMAIN_2 | 2.38e-03 | 41 | 33 | 2 | PS50014 | |
| Domain | SET | 2.38e-03 | 41 | 33 | 2 | PF00856 | |
| Domain | Znf_C2H2-like | 2.43e-03 | 796 | 33 | 6 | IPR015880 | |
| Domain | BROMO | 2.49e-03 | 42 | 33 | 2 | SM00297 | |
| Domain | Bromodomain | 2.49e-03 | 42 | 33 | 2 | IPR001487 | |
| Domain | - | 2.49e-03 | 42 | 33 | 2 | 1.20.920.10 | |
| Domain | VWF_dom | 2.49e-03 | 42 | 33 | 2 | IPR001007 | |
| Domain | Znf_RING | 2.50e-03 | 326 | 33 | 4 | IPR001841 | |
| Domain | Znf_C2H2 | 2.57e-03 | 805 | 33 | 6 | IPR007087 | |
| Domain | ZnF_C2H2 | 2.62e-03 | 808 | 33 | 6 | SM00355 | |
| Domain | Ldl_recept_a | 2.86e-03 | 45 | 33 | 2 | PF00057 | |
| Domain | - | 2.98e-03 | 46 | 33 | 2 | 4.10.400.10 | |
| Domain | LDLRA_1 | 3.25e-03 | 48 | 33 | 2 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 3.38e-03 | 49 | 33 | 2 | IPR002172 | |
| Domain | LDLa | 3.38e-03 | 49 | 33 | 2 | SM00192 | |
| Domain | LDLRA_2 | 3.38e-03 | 49 | 33 | 2 | PS50068 | |
| Domain | Laminin_G | 4.70e-03 | 58 | 33 | 2 | IPR001791 | |
| Domain | - | 6.38e-03 | 679 | 33 | 5 | 3.30.160.60 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 8.10e-07 | 59 | 18 | 4 | M39886 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.97e-06 | 20 | 18 | 3 | M27881 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.54e-05 | 5 | 18 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 1.54e-05 | 5 | 18 | 2 | M48020 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 1.54e-05 | 5 | 18 | 2 | M27228 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 1.54e-05 | 5 | 18 | 2 | M48023 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 2.30e-05 | 6 | 18 | 2 | M22062 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.74e-05 | 47 | 18 | 3 | M7946 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 3.22e-05 | 7 | 18 | 2 | MM1573 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 3.93e-05 | 53 | 18 | 3 | MM15880 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 4.29e-05 | 8 | 18 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 4.29e-05 | 8 | 18 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 4.29e-05 | 8 | 18 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 4.29e-05 | 8 | 18 | 2 | M46443 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 4.40e-05 | 55 | 18 | 3 | M39351 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 5.51e-05 | 9 | 18 | 2 | M47451 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 6.89e-05 | 10 | 18 | 2 | M27945 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 7.61e-05 | 66 | 18 | 3 | M18 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 8.32e-05 | 68 | 18 | 3 | M27303 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 8.41e-05 | 11 | 18 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 8.41e-05 | 11 | 18 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 8.41e-05 | 11 | 18 | 2 | M26924 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 8.69e-05 | 69 | 18 | 3 | M48052 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 1.01e-04 | 12 | 18 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.01e-04 | 12 | 18 | 2 | M27765 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.16e-04 | 76 | 18 | 3 | MM14867 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.39e-04 | 14 | 18 | 2 | M27808 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 1.45e-04 | 82 | 18 | 3 | M594 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.60e-04 | 15 | 18 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.60e-04 | 15 | 18 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.60e-04 | 15 | 18 | 2 | MM1439 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 1.60e-04 | 15 | 18 | 2 | M953 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.62e-04 | 85 | 18 | 3 | M16441 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 1.67e-04 | 86 | 18 | 3 | M2642 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.83e-04 | 16 | 18 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.83e-04 | 16 | 18 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.83e-04 | 16 | 18 | 2 | M8516 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 1.83e-04 | 16 | 18 | 2 | M27121 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 1.83e-04 | 16 | 18 | 2 | M27940 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.07e-04 | 17 | 18 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 2.07e-04 | 17 | 18 | 2 | M48025 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 2.33e-04 | 18 | 18 | 2 | M26942 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.60e-04 | 19 | 18 | 2 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 2.60e-04 | 19 | 18 | 2 | M46442 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 2.69e-04 | 101 | 18 | 3 | MM15829 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 2.69e-04 | 101 | 18 | 3 | M39387 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 3.19e-04 | 21 | 18 | 2 | M39593 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 3.19e-04 | 21 | 18 | 2 | M27485 | |
| Pathway | REACTOME_ADIPOGENESIS | 3.46e-04 | 110 | 18 | 3 | M48259 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 3.50e-04 | 22 | 18 | 2 | MM1443 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.50e-04 | 22 | 18 | 2 | MM1370 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 3.83e-04 | 23 | 18 | 2 | M2821 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 4.18e-04 | 24 | 18 | 2 | M13404 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 4.36e-04 | 119 | 18 | 3 | M607 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.54e-04 | 25 | 18 | 2 | M27880 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 4.91e-04 | 26 | 18 | 2 | M2499 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 4.91e-04 | 26 | 18 | 2 | M32 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 5.30e-04 | 27 | 18 | 2 | M27217 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 5.71e-04 | 28 | 18 | 2 | M27254 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 5.71e-04 | 28 | 18 | 2 | M6177 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 6.56e-04 | 30 | 18 | 2 | M207 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 6.56e-04 | 30 | 18 | 2 | M39641 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 6.56e-04 | 30 | 18 | 2 | M936 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 6.56e-04 | 30 | 18 | 2 | MM15812 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 7.01e-04 | 140 | 18 | 3 | M27484 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 7.46e-04 | 143 | 18 | 3 | M27275 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 7.47e-04 | 32 | 18 | 2 | M39521 | |
| Pathway | WP_MALE_INFERTILITY | 7.77e-04 | 145 | 18 | 3 | M39856 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 8.40e-04 | 149 | 18 | 3 | M27888 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 8.43e-04 | 34 | 18 | 2 | M39771 | |
| Pathway | PID_HIF2PATHWAY | 8.43e-04 | 34 | 18 | 2 | M44 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 8.94e-04 | 35 | 18 | 2 | M48246 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.05e-03 | 38 | 18 | 2 | M27757 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 1.05e-03 | 38 | 18 | 2 | M27255 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.11e-03 | 39 | 18 | 2 | MM14604 | |
| Pathway | PID_FOXM1_PATHWAY | 1.17e-03 | 40 | 18 | 2 | M176 | |
| Pathway | PID_IFNG_PATHWAY | 1.17e-03 | 40 | 18 | 2 | M161 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 1.29e-03 | 42 | 18 | 2 | M17541 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 1.35e-03 | 43 | 18 | 2 | M39565 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.35e-03 | 43 | 18 | 2 | M53 | |
| Pathway | PID_HNF3A_PATHWAY | 1.41e-03 | 44 | 18 | 2 | M285 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 1.41e-03 | 44 | 18 | 2 | M27295 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.48e-03 | 45 | 18 | 2 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.54e-03 | 46 | 18 | 2 | MM15971 | |
| Pathway | PID_HES_HEY_PATHWAY | 1.68e-03 | 48 | 18 | 2 | M288 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.68e-03 | 48 | 18 | 2 | M611 | |
| Pathway | PID_FOXO_PATHWAY | 1.75e-03 | 49 | 18 | 2 | M136 | |
| Pathway | REACTOME_HEME_SIGNALING | 1.75e-03 | 49 | 18 | 2 | M41832 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.75e-03 | 49 | 18 | 2 | M618 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 1.97e-03 | 52 | 18 | 2 | M2404 | |
| Pathway | PID_NFAT_3PATHWAY | 2.04e-03 | 53 | 18 | 2 | M113 | |
| Pathway | PID_AR_TF_PATHWAY | 2.04e-03 | 53 | 18 | 2 | M151 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.36e-03 | 57 | 18 | 2 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.44e-03 | 58 | 18 | 2 | M2049 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 2.44e-03 | 58 | 18 | 2 | M29616 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.52e-03 | 59 | 18 | 2 | M27218 | |
| Pathway | PID_NOTCH_PATHWAY | 2.52e-03 | 59 | 18 | 2 | M17 | |
| Pathway | PID_P53_REGULATION_PATHWAY | 2.52e-03 | 59 | 18 | 2 | M261 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 2.57e-03 | 220 | 18 | 3 | M27794 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 2.70e-03 | 61 | 18 | 2 | M39540 | |
| Pubmed | 4.59e-15 | 6 | 35 | 5 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 4.59e-15 | 6 | 35 | 5 | 25930072 | |
| Pubmed | 3.21e-11 | 24 | 35 | 5 | 32212159 | ||
| Pubmed | 7.96e-07 | 71 | 35 | 4 | 33541421 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 9.84e-07 | 2 | 35 | 2 | 34845315 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 19729597 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 15860545 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 29460469 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 9.84e-07 | 2 | 35 | 2 | 24551300 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 33911074 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 9018065 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 24648406 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 30135524 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 39287984 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 9.84e-07 | 2 | 35 | 2 | 16596650 | |
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 9.84e-07 | 2 | 35 | 2 | 29217654 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 20717166 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 10049825 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 9.84e-07 | 2 | 35 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 9.84e-07 | 2 | 35 | 2 | 29170789 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 25893291 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 11559821 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 21555743 | ||
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 9.84e-07 | 2 | 35 | 2 | 12646247 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 32576962 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 19822209 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 24522976 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 11867645 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 9.84e-07 | 2 | 35 | 2 | 21847097 | |
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 9.84e-07 | 2 | 35 | 2 | 11963968 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 9.84e-07 | 2 | 35 | 2 | 34813504 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 9.84e-07 | 2 | 35 | 2 | 12696060 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 20301699 | ||
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 9.84e-07 | 2 | 35 | 2 | 36109165 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 24639469 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 37816914 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 12242694 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 9.84e-07 | 2 | 35 | 2 | 11438528 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 10918613 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 31182547 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 35502657 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 30635043 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 31898871 | ||
| Pubmed | Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. | 9.84e-07 | 2 | 35 | 2 | 27648933 | |
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 9.84e-07 | 2 | 35 | 2 | 30888860 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 9.84e-07 | 2 | 35 | 2 | 27881443 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 19272189 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 10610021 | ||
| Pubmed | Emerging roles of p300/CBP in autophagy and autophagy-related human disorders. | 9.84e-07 | 2 | 35 | 2 | 37314181 | |
| Pubmed | Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. | 9.84e-07 | 2 | 35 | 2 | 12397173 | |
| Pubmed | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding. | 9.84e-07 | 2 | 35 | 2 | 15641773 | |
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 9.84e-07 | 2 | 35 | 2 | 32690000 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 9733868 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 30953353 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 21803292 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 9811832 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 24089570 | ||
| Pubmed | Rubinstein-Taybi syndrome in Chinese population with four novel mutations. | 9.84e-07 | 2 | 35 | 2 | 33063428 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 34506759 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 22177454 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 15706485 | ||
| Pubmed | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | 9.84e-07 | 2 | 35 | 2 | 39266679 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 22303793 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 34732714 | ||
| Pubmed | Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition. | 9.84e-07 | 2 | 35 | 2 | 34019788 | |
| Pubmed | Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. | 2.95e-06 | 3 | 35 | 2 | 14716005 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 18070920 | ||
| Pubmed | The acetylation of transcription factor HBP1 by p300/CBP enhances p16INK4A expression. | 2.95e-06 | 3 | 35 | 2 | 21967847 | |
| Pubmed | CBP and p300 are essential for renin cell identity and morphological integrity of the kidney. | 2.95e-06 | 3 | 35 | 2 | 19252086 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 27903646 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 12748286 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 10075656 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 24340053 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 19273602 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 15649887 | ||
| Pubmed | Expression patterns of histone acetyltransferases p300 and CBP during murine tooth development. | 2.95e-06 | 3 | 35 | 2 | 22179676 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 17410209 | ||
| Pubmed | DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes. | 2.95e-06 | 3 | 35 | 2 | 26951377 | |
| Pubmed | CBP/p300 and SIRT1 are involved in transcriptional regulation of S-phase specific histone genes. | 2.95e-06 | 3 | 35 | 2 | 21789216 | |
| Pubmed | Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. | 2.95e-06 | 3 | 35 | 2 | 12050117 | |
| Pubmed | Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression. | 2.95e-06 | 3 | 35 | 2 | 16237459 | |
| Pubmed | A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis. | 2.95e-06 | 3 | 35 | 2 | 12384703 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 10350644 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 29145650 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 7870179 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 19041714 | ||
| Pubmed | Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. | 2.95e-06 | 3 | 35 | 2 | 12776737 | |
| Pubmed | Convergence of Canonical and Non-Canonical Wnt Signal: Differential Kat3 Coactivator Usage. | 2.95e-06 | 3 | 35 | 2 | 30836930 | |
| Pubmed | Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. | 2.95e-06 | 3 | 35 | 2 | 14759370 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 10673036 | ||
| Pubmed | Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. | 2.95e-06 | 3 | 35 | 2 | 12456660 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 22474372 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 9488451 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 15782138 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 28302137 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 28831000 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 10893273 | ||
| Pubmed | p300/CREB-binding protein interacts with ATR and is required for the DNA replication checkpoint. | 2.95e-06 | 3 | 35 | 2 | 17272271 | |
| Interaction | SMAD1 interactions | 2.93e-06 | 243 | 34 | 6 | int:SMAD1 | |
| Interaction | MAML2 interactions | 2.94e-06 | 17 | 34 | 3 | int:MAML2 | |
| Interaction | SMAD2 interactions | 3.03e-06 | 385 | 34 | 7 | int:SMAD2 | |
| Interaction | ZBTB17 interactions | 8.37e-06 | 77 | 34 | 4 | int:ZBTB17 | |
| Interaction | NTN5 interactions | 8.67e-06 | 24 | 34 | 3 | int:NTN5 | |
| Interaction | HOXB2 interactions | 3.02e-05 | 36 | 34 | 3 | int:HOXB2 | |
| Interaction | ZDHHC15 interactions | 5.66e-05 | 125 | 34 | 4 | int:ZDHHC15 | |
| Interaction | HDAC1 interactions | 6.68e-05 | 1108 | 34 | 9 | int:HDAC1 | |
| Interaction | SMAD3 interactions | 9.14e-05 | 447 | 34 | 6 | int:SMAD3 | |
| Interaction | ITGAE interactions | 9.87e-05 | 9 | 34 | 2 | int:ITGAE | |
| Interaction | HOXB3 interactions | 9.87e-05 | 9 | 34 | 2 | int:HOXB3 | |
| Interaction | ARGFX interactions | 9.87e-05 | 9 | 34 | 2 | int:ARGFX | |
| Interaction | BCL3 interactions | 1.14e-04 | 56 | 34 | 3 | int:BCL3 | |
| Interaction | CHRDL1 interactions | 1.51e-04 | 11 | 34 | 2 | int:CHRDL1 | |
| Interaction | HRG interactions | 1.63e-04 | 63 | 34 | 3 | int:HRG | |
| Interaction | ZNF672 interactions | 1.80e-04 | 12 | 34 | 2 | int:ZNF672 | |
| Interaction | FBLN2 interactions | 1.87e-04 | 66 | 34 | 3 | int:FBLN2 | |
| Interaction | ZNF8 interactions | 2.22e-04 | 70 | 34 | 3 | int:ZNF8 | |
| Interaction | SMAD4 interactions | 2.31e-04 | 530 | 34 | 6 | int:SMAD4 | |
| Interaction | RNASE4 interactions | 2.48e-04 | 14 | 34 | 2 | int:RNASE4 | |
| Interaction | PROK2 interactions | 2.48e-04 | 14 | 34 | 2 | int:PROK2 | |
| Interaction | MAML1 interactions | 2.52e-04 | 73 | 34 | 3 | int:MAML1 | |
| Interaction | TGS1 interactions | 2.73e-04 | 75 | 34 | 3 | int:TGS1 | |
| Interaction | IGFL3 interactions | 2.73e-04 | 75 | 34 | 3 | int:IGFL3 | |
| Interaction | KLF2 interactions | 2.86e-04 | 15 | 34 | 2 | int:KLF2 | |
| Interaction | HSF2 interactions | 3.18e-04 | 79 | 34 | 3 | int:HSF2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 1.58e-05 | 8 | 35 | 2 | chr9q12 | |
| Cytoband | 9p13.1 | 1.54e-04 | 24 | 35 | 2 | 9p13.1 | |
| GeneFamily | Low density lipoprotein receptors | 9.00e-05 | 13 | 20 | 2 | 634 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.57e-04 | 17 | 20 | 2 | 486 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 1.57e-04 | 17 | 20 | 2 | 1197 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.76e-04 | 18 | 20 | 2 | 91 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 9.18e-04 | 718 | 20 | 5 | 28 | |
| GeneFamily | Ring finger proteins | 3.28e-03 | 275 | 20 | 3 | 58 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 4.88e-03 | 95 | 20 | 2 | 59 | |
| GeneFamily | Ankyrin repeat domain containing | 2.89e-02 | 242 | 20 | 2 | 403 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.34e-05 | 186 | 35 | 4 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-05 | 189 | 35 | 4 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-05 | 191 | 35 | 4 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-05 | 192 | 35 | 4 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-05 | 192 | 35 | 4 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-05 | 192 | 35 | 4 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-05 | 194 | 35 | 4 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.58e-05 | 194 | 35 | 4 | 2260cd817a6661e5eb6645b0c6786e18fd58371e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-05 | 194 | 35 | 4 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-05 | 196 | 35 | 4 | 01cea0bb0b938d0986fd2ddae06597b8af1768ee | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.68e-05 | 197 | 35 | 4 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.68e-05 | 197 | 35 | 4 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.71e-05 | 198 | 35 | 4 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.75e-05 | 199 | 35 | 4 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.78e-05 | 200 | 35 | 4 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.78e-05 | 200 | 35 | 4 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.78e-05 | 200 | 35 | 4 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.78e-05 | 200 | 35 | 4 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 134 | 35 | 3 | a3547a68012d879d4dfe80394eace70808722e43 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 134 | 35 | 3 | 9458e2d0dbc18d9025b66b59f3ecc2fbc5384940 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-04 | 149 | 35 | 3 | 7e295b2b82dea0754e98f8cef788e2781e5d641f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-04 | 149 | 35 | 3 | b4f77dc5f9d08b249fe5cd9a0acf86308c528ef4 | |
| ToppCell | IIF-Lymphocyte-T_NK-ILC|IIF / Disease, Lineage and Cell Type | 2.61e-04 | 159 | 35 | 3 | 55e4f21548f480ca414c00cbff5ec3b13bafd271 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.76e-04 | 162 | 35 | 3 | 3f264263878af630921911c2b344ac56eb1e7099 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-04 | 167 | 35 | 3 | cb650f74306fa0d9f4bf49890b73065d193b94dc | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.07e-04 | 168 | 35 | 3 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 169 | 35 | 3 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.17e-04 | 170 | 35 | 3 | 8465c3069bbc08705d070927e712b6bc85ac7c5b | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.28e-04 | 172 | 35 | 3 | a9e13aa36087170dadca421ba9de588e5a1cf715 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-04 | 175 | 35 | 3 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 3.45e-04 | 175 | 35 | 3 | 16849ea8f0985108baa2085f34c3de14a4f9f28b | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-04 | 176 | 35 | 3 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | ASK452-Endothelial-Lymphatic|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.51e-04 | 176 | 35 | 3 | b4d280ecc07701d526f50d44c45ea91b3eeb00b1 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.51e-04 | 176 | 35 | 3 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.51e-04 | 176 | 35 | 3 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-04 | 176 | 35 | 3 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.63e-04 | 178 | 35 | 3 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-04 | 181 | 35 | 3 | 0ec9621a078d004bbd25a587757d24b5cf162959 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-04 | 181 | 35 | 3 | c7f5aedcb74c21fb587a95a16d700e2a38a380ee | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 3.81e-04 | 181 | 35 | 3 | cc7ae1221a28bc404138a7efee0ad08a19cc3d86 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-04 | 182 | 35 | 3 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-04 | 182 | 35 | 3 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-04 | 182 | 35 | 3 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-04 | 182 | 35 | 3 | f4b74c2756989812abe4e7055ec8918f69d56025 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.94e-04 | 183 | 35 | 3 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-04 | 184 | 35 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-04 | 184 | 35 | 3 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-04 | 185 | 35 | 3 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.06e-04 | 185 | 35 | 3 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-04 | 186 | 35 | 3 | 35c88cc4eb388811fcac4323b549e5897fa8dc27 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-04 | 186 | 35 | 3 | d998c5b00083cf2a7cd5341a98b7374b4de73c63 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.13e-04 | 186 | 35 | 3 | 827f2f2ddde315d1e5970dd56f906c555ec699af | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.13e-04 | 186 | 35 | 3 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.13e-04 | 186 | 35 | 3 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.19e-04 | 187 | 35 | 3 | 7ea8731288e2a99f45e3958590ee1d76f49ae888 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 4.19e-04 | 187 | 35 | 3 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|kidney / Disease (COVID-19 only), tissue and cell type | 4.19e-04 | 187 | 35 | 3 | 2ce8038d9d1302e850c1bb536e755598f77ba4b9 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.26e-04 | 188 | 35 | 3 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.26e-04 | 188 | 35 | 3 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | P15-Mesenchymal|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.26e-04 | 188 | 35 | 3 | f1ba0b661621a65c91432e62ba73531bdf18e7c1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-04 | 188 | 35 | 3 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-04 | 188 | 35 | 3 | 3cee9916399e2e7580cecbcbb27424a71e7e7ac0 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 4.33e-04 | 189 | 35 | 3 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-04 | 189 | 35 | 3 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 4.33e-04 | 189 | 35 | 3 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.33e-04 | 189 | 35 | 3 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-04 | 189 | 35 | 3 | 562f8bf5a7d38afb4a8f2415d617d5f79cfb7e3f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.33e-04 | 189 | 35 | 3 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.33e-04 | 189 | 35 | 3 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.33e-04 | 189 | 35 | 3 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 4.33e-04 | 189 | 35 | 3 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-04 | 189 | 35 | 3 | 270dd4a0fc5260288fe6829837942c78b40ecec4 | |
| ToppCell | droplet-Limb_Muscle|droplet / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-04 | 190 | 35 | 3 | 06c2b13fa88abbcb8086f13b8d98a156e41e4198 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.39e-04 | 190 | 35 | 3 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 4.39e-04 | 190 | 35 | 3 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.39e-04 | 190 | 35 | 3 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.39e-04 | 190 | 35 | 3 | 3dcadabbefe0128a5f30ab51234f049ab4d870c6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.39e-04 | 190 | 35 | 3 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 4.39e-04 | 190 | 35 | 3 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.39e-04 | 190 | 35 | 3 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.39e-04 | 190 | 35 | 3 | cc17ab84a9328124f146951c06be3eff9650d9fd | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.46e-04 | 191 | 35 | 3 | 9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.46e-04 | 191 | 35 | 3 | 5c4e4e9de14edfae072a2a2882220a31bebf51b2 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-3|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.46e-04 | 191 | 35 | 3 | 80d30d8eedb4c70b58440646325bc04c5700803e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-04 | 191 | 35 | 3 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.46e-04 | 191 | 35 | 3 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 191 | 35 | 3 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 191 | 35 | 3 | 1b26056df078674f37a6c06f6256b30cfcec21a7 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.46e-04 | 191 | 35 | 3 | 80484d39f34703a33b9bac09826b7a526e883cab | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.46e-04 | 191 | 35 | 3 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.53e-04 | 192 | 35 | 3 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.53e-04 | 192 | 35 | 3 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.53e-04 | 192 | 35 | 3 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 192 | 35 | 3 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 192 | 35 | 3 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.53e-04 | 192 | 35 | 3 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 192 | 35 | 3 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-04 | 192 | 35 | 3 | 9333aba0d04203ccccad78d82bf6359922f810a7 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 192 | 35 | 3 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.53e-04 | 192 | 35 | 3 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| Disease | Menke-Hennekam syndrome | 8.68e-07 | 2 | 28 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 8.68e-07 | 2 | 28 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 8.68e-07 | 2 | 28 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 8.68e-07 | 2 | 28 | 2 | C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 8.68e-07 | 2 | 28 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 8.68e-07 | 2 | 28 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 8.68e-07 | 2 | 28 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi Syndrome | 8.68e-07 | 2 | 28 | 2 | C0035934 | |
| Disease | systemic scleroderma (implicated_via_orthology) | 2.60e-06 | 3 | 28 | 2 | DOID:418 (implicated_via_orthology) | |
| Disease | Familial aortopathy | 2.60e-06 | 3 | 28 | 2 | cv:CN078214 | |
| Disease | Squamous cell carcinoma of esophagus | 9.99e-05 | 95 | 28 | 3 | C0279626 | |
| Disease | heart disease (biomarker_via_orthology) | 1.17e-04 | 17 | 28 | 2 | DOID:114 (biomarker_via_orthology) | |
| Disease | Liver Cirrhosis | 1.27e-04 | 103 | 28 | 3 | C0023890 | |
| Disease | Fibrosis, Liver | 1.34e-04 | 105 | 28 | 3 | C0239946 | |
| Disease | Squamous cell carcinoma | 2.20e-04 | 124 | 28 | 3 | C0007137 | |
| Disease | systemic scleroderma (is_implicated_in) | 2.37e-04 | 24 | 28 | 2 | DOID:418 (is_implicated_in) | |
| Disease | Endogenous Hyperinsulinism | 2.78e-04 | 26 | 28 | 2 | C1257963 | |
| Disease | Exogenous Hyperinsulinism | 2.78e-04 | 26 | 28 | 2 | C1257964 | |
| Disease | Compensatory Hyperinsulinemia | 2.78e-04 | 26 | 28 | 2 | C1257965 | |
| Disease | Hyperinsulinism | 3.23e-04 | 28 | 28 | 2 | C0020459 | |
| Disease | Hyperglycemia, Postprandial | 3.72e-04 | 30 | 28 | 2 | C1855520 | |
| Disease | Hyperglycemia | 3.72e-04 | 30 | 28 | 2 | C0020456 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 4.64e-04 | 160 | 28 | 3 | DOID:5844 (biomarker_via_orthology) | |
| Disease | Carcinoma, Transitional Cell | 6.96e-04 | 41 | 28 | 2 | C0007138 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AKDQQKHFPPLCCCP | 146 | Q9NVA4 | |
| CQENKCPVPFCLNIK | 1796 | Q09472 | |
| KHCQENKCPVPFCLN | 1831 | Q92793 | |
| KKCCNHCYLIKPPDN | 756 | O14646 | |
| NPNRPLAECQFCHKK | 596 | Q9NQX1 | |
| CHPLCQCPKCAPAQK | 711 | Q96NW4 | |
| FNCHKRCAPKVPNNC | 306 | Q15139 | |
| CQPGNFHCKNNRCVF | 451 | Q9Y561 | |
| CGPHEFQCKNNNCIP | 3476 | Q9NZR2 | |
| KHSKCCPAKGNQCCP | 6 | P49901 | |
| KGSQCCPPKHNHCCQ | 46 | P49901 | |
| NHCCQPKPPCCIQAR | 56 | P49901 | |
| KNQCPKELPCGHRCK | 766 | Q6ZNB6 | |
| PCCQARLNCKHCGKP | 486 | Q9UBI9 | |
| VCKCPPQFSGKHCEQ | 3971 | Q9NYQ8 | |
| NECNQAPKPCNFICK | 2446 | P35555 | |
| KNPARNCRDLKFCHP | 1256 | P02461 | |
| CPLCPKEKFRACNSH | 121 | Q7Z2T5 | |
| HKQKFQAPVCGFPCN | 1231 | Q5VVP1 | |
| KPFKCHLCNRCFGQQ | 1006 | Q9HAZ2 | |
| KQKFQAPVCGFPCNH | 1236 | Q8IWB4 | |
| DCACHKGNRNCPIQK | 401 | Q9C0A6 | |
| DLCAQKPCPRNSHCL | 846 | Q99466 | |
| FQCACCGKRFRHKPN | 236 | Q9BWE0 | |
| KQKFQAPVCGFPCNH | 1236 | Q5VYP0 | |
| CHFCCPERKFISNPQ | 56 | Q5EBN2 | |
| PCQHNLCRKCANDVF | 41 | Q9BYV2 | |
| NHGKCIKPNICQCLP | 1336 | Q8N2E2 | |
| HATANKQVCKPRNPC | 636 | P07996 | |
| KCPDACNAQHKQCLI | 366 | Q9H3R2 | |
| KQKFQAPVCGFPCNH | 1236 | Q5TZJ5 | |
| KQKFQAPVCGFPCNH | 1236 | Q5VU36 | |
| FQPCGHKSCKACINQ | 1266 | Q5XPI4 | |
| DHPVRVCFNCNKKPG | 761 | Q9HBF4 | |
| HRSDRPFKCNQCGKC | 461 | P17098 | |
| KPHRCPQCGKCFARK | 321 | Q6P9G9 | |
| ECKLPPQPKKCHFCQ | 151 | Q9H9Z2 |